{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:08:25Z","timestamp":1789729705142,"version":"4.0.1"},"reference-count":258,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"HH Sheikh Hamed bin Zayed Al Nahyan Program in Biological Valve Engineering"},{"DOI":"10.13039\/100008074","name":"Grainger Foundation","doi-asserted-by":"crossref","award":["94381008"],"award-info":[{"award-number":["94381008"]}],"id":[{"id":"10.13039\/100008074","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Mayo Clinic Center for Regenerative Medicine"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.jconrel.2014.10.009","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T18:22:14Z","timestamp":1414002134000},"page":"307-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Drug delivery in aortic valve tissue engineering"],"prefix":"10.1016","volume":"196","author":[{"given":"Soumen","family":"Jana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Simari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Spoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2014.10.009_bb0005","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0140-6736(99)00198-1","article-title":"Rethink on biological aortic valves for the elderly","volume":"354","author":"Treasure","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0010","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(10)60828-8","article-title":"Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomised controlled trial","volume":"376","author":"El-Hamamsy","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/hrt.2010.205096","article-title":"Valvular heart disease: the next cardiac epidemic","volume":"97","author":"d'Arcy","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0020","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1161\/01.ATV.0000255952.47980.c2","article-title":"Aortic valve calcification: determinants and progression in the population","volume":"27","author":"Messika-Zeitoun","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0025","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1586\/erd.09.12","article-title":"Tissue engineering of heart valves: advances and current challenges","volume":"6","author":"Mol","year":"2009","journal-title":"Expert Rev. Med. Devices"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0030","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrcardio.2012.7","article-title":"World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease\u2014an evidence-based guideline","volume":"9","author":"Remenyi","year":"2012","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0035","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.addr.2011.01.008","article-title":"Aortic valve disease and treatment: the need for naturally engineered solutions","volume":"63","author":"Butcher","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0040","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/heart.87.4.395","article-title":"The medical management of valvar heart disease","volume":"87","author":"Boon","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0045","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/ncpcardio0112","article-title":"Will heart valve tissue engineering change the world?","volume":"2","author":"Yacoub","year":"2005","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0050","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0735-1097(99)00584-7","article-title":"Observed and relative survival after aortic valve replacement","volume":"35","author":"Kvidal","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0055","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1471-0528.2012.03359.x","article-title":"Low-molecular-weight heparin or warfarin for anticoagulation in pregnant women with mechanical heart valves: what are the risks? A retrospective observational study","volume":"119","author":"Basude","year":"2012","journal-title":"Bjog-an Int. J. Obstet. Gynaecol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0060","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0735-1097(00)00834-2","article-title":"Outcomes 15years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial","volume":"36","author":"Hammermeister","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0065","first-page":"362","article-title":"Tissue-engineered heart valve scaffolds","volume":"15","author":"Dohmen","year":"2009","journal-title":"Ann. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0070","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2147\/PPA.S16420","article-title":"Cardiac crossroads: deciding between mechanical or bioprosthetic heart valve replacement","volume":"5","author":"Tillquist","year":"2011","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0075","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.addr.2011.01.007","article-title":"Substrates for cardiovascular tissue engineering","volume":"63","author":"Bouten","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0080","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/01.RES.0000141146.95728.da","article-title":"Heart valve development\u2014endothelial cell signaling and differentiation","volume":"95","author":"Armstrong","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0085","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S1461-5347(00)00242-X","article-title":"The importance of drug delivery systems in tissue engineering","volume":"3","author":"Tabata","year":"2000","journal-title":"Pharm. Sci. Technol. Today"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0090","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/j.jvca.2012.12.006","article-title":"Three-dimensional echocardiography and en face views of the aortic valve: technical communication","volume":"27","author":"Kim","year":"2013","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0095","first-page":"407","article-title":"Aortic root geometry: pattern of differences between leaflets and sinuses of valsalva","volume":"8","author":"Choo","year":"1999","journal-title":"J. Heart Valve Dis."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0100","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1161\/hc4601.099489","article-title":"Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves","volume":"104","author":"Rabkin","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0105","first-page":"29","article-title":"Heart valve structure and function in development and disease","volume":"73","author":"Hinton","year":"2011"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0110","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1098\/rstb.2007.2122","article-title":"Heart valve function: a biomechanical perspective","volume":"362","author":"Sacks","year":"2007","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0115","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/CIRCRESAHA.109.201566","article-title":"Heart valve development regulatory networks in development and disease","volume":"105","author":"Combs","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0120","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1161\/CIRCRESAHA.110.234237","article-title":"Cell-matrix interactions in the pathobiology of calcific aortic valve disease: critical roles for matricellular, matricrine, and matrix mechanics cues","volume":"108","author":"Chen","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0125","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/heart.89.8.949","article-title":"Development of the heart: (2)\u2014septation of the atriums and ventricles","volume":"89","author":"Anderson","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/dvdy.20051","article-title":"Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos","volume":"230","author":"Lincoln","year":"2004","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0135","first-page":"841","article-title":"Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves","volume":"13","author":"Rabkin-Aikawa","year":"2004","journal-title":"J. Heart Valve Dis."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0140","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1006\/dbio.2002.0731","article-title":"Temporal and distinct TGF beta ligand requirements during mouse and avian endocardial cushion morphogenesis","volume":"248","author":"Camenisch","year":"2002","journal-title":"Dev. Biol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0145","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/CIRCRESAHA.107.148684","article-title":"Transitions in early embryonic atrioventricular valvular function correspond with changes in cushion biomechanics that are predictable by tissue composition","volume":"100","author":"Butcher","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0150","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/(SICI)1097-0185(20000201)258:2<119::AID-AR1>3.0.CO;2-U","article-title":"Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: roles of transforming growth factor (TGF)-beta and bone morphogenetic protein (BMP)","volume":"258","author":"Nakajima","year":"2000","journal-title":"Anat. Rec."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/dbio.2000.9750","article-title":"Slug is an essential target of TGF beta 2 signaling in the developing chicken heart","volume":"223","author":"Romano","year":"2000","journal-title":"Dev. Biol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0160","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1083\/jcb.200403050","article-title":"beta-Catenin is required for endothelial\u2013mesenchymal transformation during heart cushion development in the mouse","volume":"166","author":"Liebner","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0165","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1242\/dev.02156","article-title":"Bmp2 is essential for cardiac cushion epithelial\u2013mesenchymal transition and myocardial patterning","volume":"132","author":"Ma","year":"2005","journal-title":"Development"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0170","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1006\/dbio.2001.0284","article-title":"Bmp6 and Bmp7 are required for cushion formation and septation in the developing mouse heart","volume":"235","author":"Kim","year":"2001","journal-title":"Dev. Biol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0175","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0012-1606(03)00099-X","article-title":"Fibroblast growth factor (FGF)-4 can induce proliferation of cardiac cushion mesenchymal cells during early valve leaflet formation","volume":"258","author":"Sugi","year":"2003","journal-title":"Dev. Biol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0180","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1101\/gad.276304","article-title":"Notch promotes epithelial\u2013mesenchymal transition during cardiac development and oncogenic transformation","volume":"18","author":"Timmerman","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0185","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ydbio.2007.02.002","article-title":"Sox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve development","volume":"305","author":"Lincoln","year":"2007","journal-title":"Dev. Biol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0190","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1002\/dvdy.21246","article-title":"Monitoring Notch1 activity in development: Evidence for a feedback regulatory loop","volume":"236","author":"Del Monte","year":"2007","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0195","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1074\/jbc.M702687200","article-title":"Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling","volume":"283","author":"Zhou","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0200","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/dbio.2002.0707","article-title":"Fgf4 positively regulates scleraxis and tenascin expression in chick limb tendons","volume":"247","author":"Edom-Vovard","year":"2002","journal-title":"Dev. Biol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0205","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.actbio.2014.03.014","article-title":"Scaffolds for tissue engineering of cardiac valves","volume":"10","author":"Jana","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0210","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/01.CIR.0000027621.26167.5E","article-title":"Cardiology patient pages. Aortic valve disease","volume":"106","author":"Nishimura","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0215","doi-asserted-by":"crossref","first-page":"i11","DOI":"10.1093\/ejechocard\/jen240","article-title":"Aortic stenosis","volume":"10","author":"Chambers","year":"2009","journal-title":"Eur. J. Echocardiogr."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0220","first-page":"135","article-title":"The need for a global perspective on heart valve disease epidemiology. The SHVD working group on epidemiology of heart valve disease founding statement","volume":"17","author":"Takkenberg","year":"2008","journal-title":"J. Heart Valve Dis."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0225","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa065085","article-title":"Prevalence of rheumatic heart disease detected by echocardiographic screening","volume":"357","author":"Marijon","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0230","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1172\/JCI108216","article-title":"Adherence of bacteria to heart valves in vitro","volume":"56","author":"Gould","year":"1975","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0235","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.molimm.2003.11.023","article-title":"T cell mimicry in inflammatory heart disease","volume":"40","author":"Cunningham","year":"2004","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0240","doi-asserted-by":"crossref","first-page":"C658","DOI":"10.1152\/ajpcell.00313.2011","article-title":"A dynamic model of calcific nodule destabilization in response to monocyte- and oxidized lipid-induced matrix metalloproteinases","volume":"302","author":"Li","year":"2012","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0245","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1161\/CIRCULATIONAHA.108.805911","article-title":"Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering","volume":"118","author":"Schoen","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0250","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1161\/01.CIR.0000015343.76143.13","article-title":"Evaluation and management of patients with aortic stenosis","volume":"105","author":"Carabello","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0255","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJM195104052441403","article-title":"The importance of high-pitched squeaking systolic murmur in the diagnosis of aortic stenosis and calcification of the aortic valve","volume":"244","author":"Braun","year":"1951","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0260","first-page":"471","article-title":"Indications for and objectives of cardiac catheterization in aortic valve disease","volume":"126","author":"Johnson","year":"1977","journal-title":"West. J. Med."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0265","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.addr.2007.03.012","article-title":"Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications","volume":"59","author":"Malafaya","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0270","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.addr.2007.08.038","article-title":"Controlled drug delivery in tissue engineering","volume":"60","author":"Biondi","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0275","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.addr.2007.04.001","article-title":"Polymer carriers for drug delivery in tissue engineering","volume":"59","author":"Sokolsky-Papkov","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0280","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/j.jamcollsurg.2012.06.319","article-title":"Viral-mediated gene therapy in combination with temozolomide in melanoma","volume":"215","author":"Egger","year":"2012","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0285","first-page":"A145","article-title":"Gene therapy for liver diseases using non-viral minicircle-DNA vector","volume":"23","author":"Viecelli","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0290","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijpharm.2013.12.015","article-title":"Natural and synthetic polymers for wounds and burns dressing","volume":"463","author":"Mogosanu","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0295","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.3390\/ma3031863","article-title":"Collagen-based biomaterials for tissue engineering applications","volume":"3","author":"Parenteau-Bareil","year":"2010","journal-title":"Materials"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0300","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/jbm.b.32856","article-title":"Preparation and properties of tannic acid cross-linked collagen scaffold and its application in wound healing","volume":"101B","author":"Natarajan","year":"2013","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0305","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.addr.2003.08.008","article-title":"Recombinant collagen and gelatin for drug delivery","volume":"55","author":"Olsen","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0310","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1089\/ten.tea.2008.0263","article-title":"Stabilized collagen scaffolds for heart valve tissue engineering","volume":"15","author":"Tedder","year":"2009","journal-title":"Tissue Eng. A"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0315","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2106\/JBJS.K.00225","article-title":"Axonal loss in murine peripheral nerves following exposure to recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge","volume":"95","author":"Margolis","year":"2013","journal-title":"J. Bone Joint Surg."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0320","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.2012.06718.x","article-title":"Controlled delivery of thymosin \u03b24 for tissue engineering and cardiac regenerative medicine","volume":"1269","author":"Chiu","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0325","doi-asserted-by":"crossref","first-page":"124","DOI":"10.18433\/J39K5H","article-title":"Organic glues or fibrin glues from pooled plasma: efficacy. safety and potential as scaffold delivery systems","volume":"15","author":"Tabele","year":"2012","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1098\/rsif.2008.0327","article-title":"Fibrin gels and their clinical and bioengineering applications","volume":"6","author":"Janmey","year":"2009","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0335","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1089\/ten.2006.12.891","article-title":"Tissue-engineered valves with commissural alignment","volume":"12","author":"Neidert","year":"2006","journal-title":"Tissue Eng."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0340","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.nano.2011.05.016","article-title":"Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging","volume":"8","author":"Parveen","year":"2012","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0345","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1010-7940(01)00624-8","article-title":"Fibrin gel\u2014advantages of a new scaffold in cardiovascular tissue engineering","volume":"19","author":"Jockenhoevel","year":"2001","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0350","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1525-1594.2011.01420.x","article-title":"The effect of the delivery carrier on the quality of bone formed via bone morphogenetic protein-2","volume":"36","author":"La","year":"2012","journal-title":"Artif. Organs"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0355","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/23\/9\/095102","article-title":"Fibrin nanoconstructs: a novel processing method and their use as controlled delivery agents","volume":"23","author":"Praveen","year":"2012","journal-title":"Nanotechnology"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0360","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1242\/jcs.00059","article-title":"Fibronectin at a glance","volume":"115","author":"Pankov","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0365","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.carpath.2007.02.008","article-title":"Cardiac valve interstitial cells secrete fibronectin and form fibrillar adhesions in response to injury","volume":"16","author":"Fayet","year":"2007","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0370","doi-asserted-by":"crossref","first-page":"72-72","DOI":"10.1161\/circ.116.suppl_16.II_72","article-title":"A new drug delivery system using fibronectin\u2013VEGF fusion is more effective and harmless than vegf alone for the therapeutic neovascularization","volume":"116","author":"Inoue","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0375","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/term.154","article-title":"Laminin and fibronectin scaffolds enhance neural stem cell transplantation into the injured brain","volume":"3","author":"Tate","year":"2009","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0380","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.actbio.2010.11.010","article-title":"Conjugation of fibronectin onto three-dimensional porous scaffolds for vascular tissue engineering applications","volume":"7","author":"Dubey","year":"2011","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0385","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1166\/jnn.2005.436","article-title":"Comparison of selective attachment and growth of smooth muscle cells on gelatin- and fibronectin-coated micropatterns","volume":"5","author":"Li","year":"2005","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0390","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/j.athoracsur.2005.05.002","article-title":"Fibronectin\u2013hepatocyte growth factor enhances reendothelialization in tissue-engineered heart valve","volume":"80","author":"Ota","year":"2005","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0395","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1098\/rsif.2007.0220","article-title":"Natural origin biodegradable systems in tissue engineering and regenerative medicine: present status and some moving trends","volume":"4","author":"Mano","year":"2007","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0400","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/jbm.a.34420","article-title":"3D Bioprinting of heterogeneous aortic valve conduits with alginate\/gelatin hydrogels","volume":"101A","author":"Duan","year":"2013","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v29.i1.10","article-title":"Scaffold: a novel carrier for cell and drug delivery","volume":"29","author":"Garg","year":"2012","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0410","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.actbio.2008.04.002","article-title":"Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2","volume":"4","author":"Patel","year":"2008","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0415","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1007\/s11095-008-9685-1","article-title":"In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds","volume":"25","author":"Patel","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0420","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1389-1723(03)80129-9","article-title":"Transglutaminase-mediated gelatin matrices incorporating cell adhesion factors as a biomaterial for tissue engineering","volume":"95","author":"Ito","year":"2003","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0425","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1001\/jamaoto.2013.92","article-title":"Treatment of neural anosmia by topical application of basic fibroblast growth factor-gelatin hydrogel in the nasal cavity: an experimental study in mice","volume":"139","author":"Nota","year":"2013","journal-title":"JAMA Otolaryngol. Head Neck Surg. Study Highlights"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0430","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0079-6700(94)90030-2","article-title":"Biodegradable polymers for biomedical uses","volume":"19","author":"Hayashi","year":"1994","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0435","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.addr.2008.09.001","article-title":"Polysaccharides-based nanoparticles as drug delivery systems","volume":"60","author":"Liu","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0440","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/10611860802455805","article-title":"Microbiota-triggered colonic delivery: Robustness of the polysaccharide approach in the fed state in man","volume":"17","author":"Basit","year":"2009","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0445","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.biomaterials.2011.10.064","article-title":"Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin","volume":"33","author":"Cho","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0450","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1007\/s10856-008-3469-3","article-title":"Synthesis and characterization of matrix metalloprotease sensitive-low molecular weight hyaluronic acid based hydrogels","volume":"19","author":"Kim","year":"2008","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0455","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/scdb.2000.0244","article-title":"Hyaluronan in morphogenesis","volume":"12","author":"Toole","year":"2001","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0460","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1517\/17425241003730399","article-title":"Nanostructured hyaluronic acid-based materials for active delivery to cancer","volume":"7","author":"Ossipov","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0465","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jconrel.2008.11.028","article-title":"An injectable hyaluronic acid-tyramine hydrogel system for protein delivery","volume":"134","author":"Lee","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0470","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/jbm.a.34349","article-title":"Different hyaluronic acid morphology modulates primary articular chondrocyte behavior in hyaluronic acid-coated polycaprolactone scaffolds","volume":"101A","author":"Lebourg","year":"2013","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0475","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1016\/S0142-9612(03)00156-X","article-title":"Tissue engineering of white adipose tissue using hyaluronic acid-based scaffolds. I: in vitro differentiation of human adipocyte precursor cells on scaffolds","volume":"24","author":"Halbleib","year":"2003","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0480","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.biomaterials.2004.03.013","article-title":"Feasibility of chitosan-based hyaluronic acid hybrid biomaterial for a novel scaffold in cartilage tissue engineering","volume":"26","author":"Yamane","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0485","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/0885328214530589","article-title":"Fiber-reinforced hydrogel scaffolds for heart valve tissue engineering","volume":"29","author":"Eslami","year":"2014","journal-title":"J. Biomater. Appl."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0490","series-title":"Department of Bioengineering, University of Kansas, Lawrence","first-page":"154","article-title":"Biomedical application of hyaluronic acid nanoparticles","author":"Fakhari","year":"2012"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0495","doi-asserted-by":"crossref","first-page":"7640","DOI":"10.1016\/j.actbio.2013.04.050","article-title":"Stiffness and adhesivity control aortic valve interstitial cell behavior within hyaluronic acid based hydrogels","volume":"9","author":"Duan","year":"2013","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0500","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1016\/j.biomaterials.2004.07.018","article-title":"Crosslinked hyaluronan scaffolds as a biologically active carrier for valvular interstitial cells","volume":"26","author":"Masters","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0505","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1039\/c2jm16676c","article-title":"High-strength pristine porous chitosan scaffolds for tissue engineering","volume":"22","author":"Jana","year":"2012","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0510","first-page":"45","article-title":"Chitosan: a promising biomaterial for tissue engineering scaffolds","author":"Dutta","year":"2011"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2006.04.017","article-title":"Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan\u2014a review","volume":"114","author":"George","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0520","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.addr.2009.08.004","article-title":"Chitosan-based formulations for delivery of DNA and siRNA","volume":"62","author":"Mao","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0525","first-page":"19","article-title":"Chitosan and chitosan derivatives in drug delivery and tissue engineering","author":"Riva","year":"2011"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0530","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jmbbm.2011.08.021","article-title":"Improving the mechanical properties of chitosan-based heart valve scaffolds using chitosan fibers","volume":"5","author":"Albanna","year":"2012","journal-title":"J. Mech. Behav. Biomed. Mater."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0535","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s12257-011-0352-8","article-title":"Alginate lyase: structure, property, and application","volume":"16","author":"Kim","year":"2011","journal-title":"Biotechnol. Bioprocess Eng."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0540","first-page":"669","article-title":"Swelling studies and in vitro release of acemetacin and BSA from alginate gel beads crosslinked with Ca2+ or Ba2+","volume":"27","author":"Yuan","year":"2012"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0545","doi-asserted-by":"crossref","first-page":"III56","DOI":"10.1161\/01.CIR.102.suppl_3.III-56","article-title":"Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium?","volume":"102","author":"Leor","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0550","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.biomaterials.2006.08.011","article-title":"Characterizing short-term release and neovascularization potential of multi-protein growth supplement delivered via alginate hollow fiber devices","volume":"28","author":"Tilakaratne","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0555","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.carbpol.2012.05.004","article-title":"In vitro and in vivo theophylline release from cellulose\/chondroitin sulfate hydrogels","volume":"90","author":"Oprea","year":"2012","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0560","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.biomaterials.2005.10.031","article-title":"A collagen-glycosaminoglycan co-culture model for heart valve tissue engineering applications","volume":"27","author":"Flanagan","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0565","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0142-9612(95)98820-5","article-title":"Cross-linked chondroitin sulphate: characterization for drug delivery purposes","volume":"16","author":"Sintov","year":"1995","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0570","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1016\/j.biomaterials.2006.04.013","article-title":"Cartilage regeneration using mesenchymal stem cells and a PLGA-gelatin\/chondroitin\/hyaluronate hybrid scaffold","volume":"27","author":"Fan","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0575","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0168-3659(00)00232-7","article-title":"Controlled release of platelet-derived growth factor-BB from chondroitin sulfate-chitosan sponge for guided bone regeneration","volume":"67","author":"Park","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0580","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.carbpol.2010.11.009","article-title":"Preparation of collagen-chondroitin sulfate-hyaluronic acid hybrid hydrogel scaffolds and cell compatibility in vitro","volume":"84","author":"Zhang","year":"2011","journal-title":"Carbohydr. Polym."},{"issue":"003","key":"10.1016\/j.jconrel.2014.10.009_bb0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1201\/b13978-16","article-title":"Collagen-based scaffolds for potential application of heart valve tissue engineering","volume":"S11","author":"Chen","year":"2012","journal-title":"J. Tissue Sci. Eng."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0590","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/jbm.a.32641","article-title":"Biocompatibility of polyhydroxyalkanoate as a potential material for ligament and tendon scaffold material","volume":"93A","author":"Rathbone","year":"2010","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057157","article-title":"Fabrication, characterization and cellular compatibility of poly(hydroxy alkanoate) composite nanofibrous scaffolds for nerve tissue engineering","volume":"8","author":"Masaeli","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0600","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.plasmid.2009.08.002","article-title":"Construction of PHB and PHBV multiple-gene vectors driven by an oil palm leaf-specific promoter","volume":"62","author":"Masani","year":"2009","journal-title":"Plasmid"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0605","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1023\/A:1004740522751","article-title":"Review\u2014properties of blends and composites based on poly(3-hydroxy)butyrate (PHB) and poly(3-hydroxybutyrate-hydroxyvalerate) (PHBV) copolymers","volume":"35","author":"Avella","year":"2000","journal-title":"J. Mater. Sci."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0610","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0141-8130(99)00036-7","article-title":"Determination of solubility parameters for poly(3-hydroxyalkanoates)","volume":"25","author":"Terada","year":"1999","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0615","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s11274-010-0605-2","article-title":"Biodegradability studies of polyhydroxyalkanoate (PHA) film produced by a marine bacteria using Jatropha biodiesel byproduct as a substrate","volume":"27","author":"Shrivastav","year":"2011","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0620","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijpharm.2010.08.008","article-title":"Amphiphilic PHA-mPEG copolymeric nanocontainers for drug delivery: Preparation, characterization and in vitro evaluation","volume":"400","author":"Shah","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0625","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3724\/SP.J.1105.2009.00097","article-title":"Biodegradable polymers for controlled release of gene delivery systems","author":"Fu","year":"2009","journal-title":"Acta Polym. Sin."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0630","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-005-9046-2","article-title":"Polymer architecture and drug delivery","volume":"23","author":"Qiu","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0635","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1002\/pola.22579","article-title":"Synthesis and characterization of functional polyesters tailored for biomedical applications","volume":"46","author":"Cerbai","year":"2008","journal-title":"J. Polym. Sci. A1 Polym. Chem."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0640","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0079-6700(01)00050-8","article-title":"Miscibility, properties, and biodegradability of microbial polyester containing blends","volume":"27","author":"Ha","year":"2002","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0645","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.procbio.2006.12.009","article-title":"Biodegradability and mechanical properties of polycaprolactone composites encapsulating phosphate-solubilizing bacterium Bacillus sp PG01","volume":"42","author":"Wu","year":"2007","journal-title":"Process Biochem."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0650","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5405\/jmbe.683","article-title":"Studies on the preparation and characterization of mpeg-polyester biodegradable bioglue for bone defect repair","volume":"31","author":"Chen","year":"2011","journal-title":"J. Med. Biol. Eng."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0655","doi-asserted-by":"crossref","DOI":"10.1007\/s11051-012-1316-4","article-title":"Biodegradable PLGA-b-PEG polymeric nanoparticles: synthesis, properties, and nanomedical applications as drug delivery system","volume":"14","author":"Locatelli","year":"2012","journal-title":"J. Nanoparticle Res."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0660","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijpharm.2012.07.006","article-title":"PEGylated-PLGA microparticles containing VEGF for long term drug delivery","volume":"440","author":"Simon-Yarza","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0665","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/1521-3927(20020401)23:5\/6<332::AID-MARC332>3.0.CO;2-I","article-title":"Poly(amido-amine)s: biomedical applications","volume":"23","author":"Ferruti","year":"2002","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0670","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0142-9612(83)90015-7","article-title":"Heparin adsorbing capacities at physiological pH of three poly(amido-amine) resins, and of poly(amido-amine)-surface-grafted glass microspheres","volume":"4","author":"Ferruti","year":"1983","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0675","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jconrel.2012.07.029","article-title":"Effects of branched or linear architecture of bioreducible poly(amido amine)s on their in vitro gene delivery properties","volume":"164","author":"Martello","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0680","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10856-008-3496-0","article-title":"Poly (vinyl alcohol) hydrogels for pH dependent colon targeted drug delivery","volume":"20","author":"Basak","year":"2009","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0685","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejpb.2009.11.002","article-title":"Characterization of a polyurethane-based controlled release system for local delivery of chlorhexidine diacetate","volume":"74","author":"Huynh","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0690","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1016\/j.biomaterials.2004.10.018","article-title":"Preparation and characterization of highly porous, biodegradable polyurethane scaffolds for soft tissue applications","volume":"26","author":"Guan","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0695","doi-asserted-by":"crossref","first-page":"E353","DOI":"10.1002\/app.36742","article-title":"New method for coupling collagen on biodegradable polyurethane for biomedical application","volume":"126","author":"He","year":"2012","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0700","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3184\/0308234041209158","article-title":"Recent research and development in synthetic polymer-based drug delivery systems","author":"Ghosh","year":"2004","journal-title":"J. Chem. Res. Synop."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0705","doi-asserted-by":"crossref","DOI":"10.1186\/1475-925X-11-92","article-title":"Use of a special bioreactor for the cultivation of a new flexible polyurethane scaffold for aortic valve tissue engineering","volume":"11","author":"Aleksieva","year":"2012","journal-title":"Biomed. Eng. Online"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0710","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrcardio.2010.1","article-title":"Cell therapy for the treatment of coronary heart disease: a critical appraisal","volume":"7","author":"Wollert","year":"2010","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0715","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.addr.2013.12.004","article-title":"Cell therapy, 3D culture systems and tissue engineering for cardiac regeneration","volume":"69\u201370","author":"Emmert","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0720","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4155\/tde.11.141","article-title":"Cell-based drug-delivery platforms","volume":"3","author":"Gutierrez Millan","year":"2012","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0725","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0003-4975(02)03776-1","article-title":"Bone marrow as a cell source for tissue engineering heart valves","volume":"75","author":"Perry","year":"2003","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0730","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1089\/ten.tea.2009.0424","article-title":"Endothelial progenitor cells as a sole source for ex vivo seeding of tissue-engineered heart valves","volume":"16","author":"Sales","year":"2010","journal-title":"Tissue Eng. A"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0735","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jtcvs.2005.11.037","article-title":"Decellularized heart valve as a scaffold for in vivo recellularization: deleterious effects of granulocyte colony-stimulating factor","volume":"131","author":"Juthier","year":"2006","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0740","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1016\/j.biomaterials.2011.11.087","article-title":"Prenatally engineered autologous amniotic fluid stem cell-based heart valves in the fetal circulation","volume":"33","author":"Weber","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0745","doi-asserted-by":"crossref","first-page":"I143","DOI":"10.1161\/01.cir.0000032872.55215.05","article-title":"Tissue engineering of functional trileaflet heart valves from human marrow stromal cells","volume":"106","author":"Hoerstrup","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0750","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.biomaterials.2010.09.003","article-title":"Extracellular matrix production by adipose-derived stem cells: implications for heart valve tissue engineering","volume":"32","author":"Colazzo","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0755","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1089\/ten.2006.12.3223","article-title":"Engineering of biologically active living heart valve leaflets using human umbilical cord-derived progenitor cells","volume":"12","author":"Schmidt","year":"2006","journal-title":"Tissue Eng."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0760","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.athoracsur.2009.11.058","article-title":"Use of human umbilical cord blood-derived progenitor cells for tissue-engineered heart valves","volume":"89","author":"Sodian","year":"2010","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0765","doi-asserted-by":"crossref","first-page":"I64","DOI":"10.1161\/CIRCULATIONAHA.106.681494","article-title":"Prenatally fabricated autologous human living heart valves based on amniotic fluid-derived progenitor cells as single cell source","volume":"116","author":"Schmidt","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0770","doi-asserted-by":"crossref","first-page":"I125","DOI":"10.1161\/CIRCULATIONAHA.105.001040","article-title":"Living autologous heart valves engineered from human prenatally harvested progenitors","volume":"114","author":"Schmidt","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0775","first-page":"446","article-title":"Cryopreserved amniotic fluid-derived cells: a lifelong autologous fetal stem cell source for heart valve tissue engineering","volume":"17","author":"Schmidt","year":"2008","journal-title":"J. Heart Valve Dis."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0780","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jacc.2010.04.024","article-title":"Minimally-invasive implantation of living tissue engineered heart valves a comprehensive approach from autologous vascular cells to stem cells","volume":"56","author":"Schmidt","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0785","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0790","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.addr.2007.08.029","article-title":"Cell-based drug delivery","volume":"60","author":"Pierige","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0795","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2174\/157488806778226821","article-title":"Adult mesenchymal stem cells: a pluripotent population with multiple applications","volume":"1","author":"Porada","year":"2006","journal-title":"Curr. Stem. Cell Res. Ther."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0800","doi-asserted-by":"crossref","first-page":"e18801","DOI":"10.1371\/journal.pone.0018801","article-title":"Dendritic cell based tumor vaccination in prostate and renal cell cancer: a systematic review and meta-analysis","volume":"6","author":"Draube","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0805","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.addr.2012.01.016","article-title":"Strategies for controlled delivery of growth factors and cells for bone regeneration","volume":"64","author":"Vo","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0810","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12265-010-9210-x","article-title":"Delivering regenerative cues to the heart: cardiac drug delivery by microspheres and peptide nanofibers","volume":"3","author":"Sy","year":"2010","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0815","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1517\/17425247.2012.641950","article-title":"Drug delivery applications for superporous hydrogels","volume":"9","author":"Mastropietro","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0820","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/10717544.2011.600783","article-title":"Comparative analysis of the methods of drug and protein delivery for the treatment of cancer, genetic diseases and diagnostics","volume":"18","author":"Todorova","year":"2011","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0825","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/jbm.a.33244","article-title":"Immobilized thermolysin for highly efficient production of low-molecular-weight protamine\u2014an attractive cell-penetrating peptide for macromolecular drug delivery applications","volume":"100A","author":"David","year":"2012","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0830","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.dental.2006.02.011","article-title":"Poly(ethylene-co-vinyl acetate) copolymer matrix for delivery of chlorhexidine and acyclovir drugs for use in the oral environment: effect of drug combination, copolymer composition and coating on the drug release rate","volume":"23","author":"Tallury","year":"2007","journal-title":"Dent. Mater."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0835","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.addr.2007.03.015","article-title":"Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering","volume":"59","author":"Chung","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0840","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/jbm.a.34305","article-title":"Laser microfabricated poly(glycerol sebacate) scaffolds for heart valve tissue engineering","volume":"101","author":"Masoumi","year":"2013","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0845","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1073\/pnas.1215498110","article-title":"Hydrogel drug delivery system with predictable and tunable drug release and degradation rates","volume":"110","author":"Ashley","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0850","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1016\/j.actbio.2011.02.018","article-title":"Flexural characterization of cell encapsulated PEGDA hydrogels with applications for tissue engineered heart valves","volume":"7","author":"Durst","year":"2011","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0855","doi-asserted-by":"crossref","first-page":"19482","DOI":"10.1039\/c2jm31778h","article-title":"Biocompatible stimuli-responsive hydrogel porous membranes via phase separation of a polyvinyl alcohol and Na-alginate intermolecular complex","volume":"22","author":"Gopishetty","year":"2012","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0860","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5082\/4\/3\/035005","article-title":"Rapid 3D printing of anatomically accurate and mechanically heterogeneous aortic valve hydrogel scaffolds","volume":"4","author":"Hockaday","year":"2012","journal-title":"Biofabrication"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0865","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1021\/nn305559j","article-title":"Carbon-nanotube-embedded hydrogel sheets for engineering cardiac constructs and bioactuators","volume":"7","author":"Shin","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0870","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1002\/adma.200802106","article-title":"Hydrogels in regenerative medicine","volume":"21","author":"Slaughter","year":"2009","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0875","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/jbm.a.33039","article-title":"Microsphere-integrated drug-eluting stents: PLGA microsphere integration in hydrogel coating for local and prolonged delivery of hydrophilic antirestenosis agents","volume":"97A","author":"Indolfi","year":"2011","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0880","first-page":"58","article-title":"Drug delivery: techniques for polymeric microsphere preparation","volume":"2","author":"Anindita","year":"2007","journal-title":"Res. J. Biotechnol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0885","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/290602","article-title":"Polymeric scaffolds in tissue engineering application: a review","volume":"2011","author":"Dhandayuthapani","year":"2011","journal-title":"Int. J. Polym. Sci."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0890","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1517\/14712598.4.1.35","article-title":"Microspheres for controlled release drug delivery","volume":"4","author":"Varde","year":"2004","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0895","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v12.i1.10","article-title":"Biodegradable microspheres in drug delivery","volume":"12","author":"Okada","year":"1995","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0900","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nmat2299","article-title":"Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction","volume":"7","author":"Sy","year":"2008","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0905","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11596-009-0513-6","article-title":"Fabrication of a novel hybrid scaffold for tissue engineered heart valve","volume":"29","author":"Hong","year":"2009","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0910","first-page":"219","article-title":"Drug delivery system using electrospun nanofiber mats","volume":"33","author":"Yoon","year":"2009","journal-title":"Polymer"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0915","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/jbm.b.30041","article-title":"Bioresorbable nanofiber-based systems for wound healing and drug delivery: optimization of fabrication parameters","volume":"70B","author":"Katti","year":"2004","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0920","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1517\/17425247.5.10.1093","article-title":"Enhanced composite electrospun nanofiber scaffolds for use in drug delivery","volume":"5","author":"Hadjiargyrou","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0925","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1039\/b902637a","article-title":"Immobilization of catalase on electrospun nanofibrous membranes modified with bovine serum albumin or collagen: coupling site-dependent activity and protein-dependent stability","volume":"5","author":"Wang","year":"2009","journal-title":"Soft Matter"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0930","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11596-011-0156-2","article-title":"Application of Decellularized Scaffold Combined with Loaded Nanoparticles for Heart Valve Tissue Engineering in vitro","volume":"31","author":"Deng","year":"2011","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0935","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2217\/nnm.12.87","article-title":"Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system","volume":"7","author":"Bamrungsap","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0940","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/IJN.S596","article-title":"Drug delivery and nanoparticles: applications and hazards","volume":"3","author":"De Jong","year":"2008","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0945","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jbiomech.2012.01.046","article-title":"Manufacturing and hydrodynamic assessment of a novel aortic valve made of a new nanocomposite polymer","volume":"45","author":"Rahmani","year":"2012","journal-title":"J. Biomech."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0950","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.biomaterials.2006.07.032","article-title":"Virus-based gene therapy strategies for bone regeneration","volume":"28","author":"Phillips","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0955","doi-asserted-by":"crossref","first-page":"378","DOI":"10.18632\/oncotarget.937","article-title":"Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma?","volume":"4","author":"Auffinger","year":"2013","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.jconrel.2014.10.009_bb0960","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.actbio.2014.03.014","article-title":"Scaffolds for tissue engineering of cardiac valves","volume":"10","author":"Jana","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0965","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1089\/ten.tea.2010.0027","article-title":"Transforming growth factor beta, bone morphogenetic protein, and vascular endothelial growth factor mediate phenotype maturation and tissue remodeling by embryonic valve progenitor cells: relevance for heart valve tissue engineering","volume":"16","author":"Chiu","year":"2010","journal-title":"Tissue Eng. A"},{"key":"10.1016\/j.jconrel.2014.10.009_bb0970","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.addr.2007.03.013","article-title":"Injectable matrices and scaffolds for drug delivery in tissue engineering","volume":"59","author":"Kretlow","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0975","first-page":"560","article-title":"Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis","volume":"13","author":"Kaden","year":"2004","journal-title":"J. Heart Valve Dis."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0980","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jtcvs.2011.10.097","article-title":"miRNA-141 is a novel regulator of BMP-2-mediated calcification in aortic stenosis","volume":"144","author":"Yanagawa","year":"2012","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0985","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jtcvs.2009.06.024","article-title":"Bone morphogenic protein 2 induces Runx2 and osteopontin expression in human aortic valve interstitial cells: role of Smad1 and extracellular signal-regulated kinase 1\/2","volume":"138","author":"Yang","year":"2009","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0990","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1089\/ten.2006.12.2707","article-title":"Growth factor modulation of fibroblast proliferation, differentiation, and invasion: implications for tissue valve engineering","volume":"12","author":"Narine","year":"2006","journal-title":"Tissue Eng."},{"key":"10.1016\/j.jconrel.2014.10.009_bb0995","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1016-8478(23)13186-4","article-title":"Transfection of mesenchymal stem cells with the FGF-2 gene improves their survival under hypoxic conditions","volume":"19","author":"Song","year":"2005","journal-title":"Mol. Cells"},{"key":"10.1016\/j.jconrel.2014.10.009_bb1000","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1161\/CIRCRESAHA.108.186742","article-title":"IGF-1-overexpressing mesenchymal stem cells accelerate bone marrow stem cell mobilization via paracrine activation of SDF-1alpha\/CXCR4 signaling to promote myocardial repair","volume":"103","author":"Haider","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5339\/qproc.2012.heartvalve.4.10","article-title":"The role of Insulin-like growth factor-1 in calcification of human aortic valves","volume":"2012","author":"Poudel-Bochmann","year":"2012","journal-title":"QSci. Proc."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/08977194.2011.634411","article-title":"An optimized growth factor cocktail for ovine mesenchymal stem cells","volume":"30","author":"Somers","year":"2012","journal-title":"Growth Factors"},{"key":"10.1016\/j.jconrel.2014.10.009_bb1015","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1114\/1.1558031","article-title":"Phenotype modulation in vascular tissue engineering using biochemical and mechanical stimulation","volume":"31","author":"Stegemann","year":"2003","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1020","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1161\/ATVBAHA.109.195271","article-title":"Statins block calcific nodule formation of valvular interstitial cells by inhibiting alpha-smooth muscle actin expression","volume":"29","author":"Benton","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10237-012-0377-8","article-title":"Calcific nodule morphogenesis by heart valve interstitial cells is strain dependent","volume":"12","author":"Fisher","year":"2013","journal-title":"Biomech. Model. Mechanobiol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1030","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0003-4975(02)04312-6","article-title":"Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis","volume":"75","author":"Jian","year":"2003","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1035","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/01.mat.0000206125.81406.02","article-title":"Construction of tissue-engineered homograft bioprosthetic heart valves in vitro","volume":"52","author":"Bin","year":"2006","journal-title":"ASAIO J."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1040","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1089\/107632703322066660","volume":"9","author":"Dvorin","year":"2003","journal-title":"Tissue Eng."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1045","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1089\/ten.tea.2010.0304","article-title":"Opposite effects of transforming growth factor-beta 1 and vascular endothelial growth factor on the degeneration of aortic valvular interstitial cell are modified by the extracellular matrix protein fibronectin: implications for heart valve engineering","volume":"16","author":"Gwanmesia","year":"2010","journal-title":"Tissue Eng. A"},{"key":"10.1016\/j.jconrel.2014.10.009_bb1050","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1242\/jcs.99.3.657","article-title":"Extracellular-matrix adhesion-promoting activities of a dermatan sulfate proteoglycan-associated protein (22K) from bovine fetal skin","volume":"99","author":"Lewandowska","year":"1991","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1055","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1046\/j.1523-1755.1999.00656.x","article-title":"Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro","volume":"56","author":"Fan","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1060","first-page":"1049","article-title":"Arg-Gly-Asp (RGD) peptide ameliorates carbon tetrachloride-induced liver fibrosis via inhibition of collagen production and acceleration of collagenase activity","volume":"14","author":"Kotoh","year":"2004","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1065","doi-asserted-by":"crossref","first-page":"12384","DOI":"10.1074\/jbc.M208544200","article-title":"Myofibroblast differentiation by transforming growth factor-beta1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase","volume":"278","author":"Thannickal","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1070","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1083\/jcb.122.1.103","article-title":"Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts","volume":"122","author":"Desmouliere","year":"1993","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1075","first-page":"281","article-title":"Transforming growth factor-beta-induced transition of fibroblasts: a model for myofibroblast procurement in tissue valve engineering","volume":"13","author":"Narine","year":"2004","journal-title":"J. Heart Valve Dis."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1080","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1358\/mf.2002.24.6.693065","article-title":"Transforming growth factor-beta(1)-induced collagen production in cultures of cardiac fibroblasts is the result of the appearance of myofibroblasts","volume":"24","author":"Lijnen","year":"2002","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1085","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1089\/ten.tea.2009.0031","article-title":"Vascular smooth muscle cells as a valvular interstitial cell surrogate in heart valve tissue engineering","volume":"15","author":"Appleton","year":"2009","journal-title":"Tissue Eng. A"},{"key":"10.1016\/j.jconrel.2014.10.009_bb1090","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1096\/fj.07-087627","article-title":"Fibroblast growth factor represses Smad-mediated myofibroblast activation in aortic valvular interstitial cells","volume":"22","author":"Cushing","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1095","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1524-475X.2007.00244.x","article-title":"Inhibition of osteogenic differentiation of human mesenchymal stem cells","volume":"15","author":"Moioli","year":"2007","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1100","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.110.220061","article-title":"beta-Catenin mediates mechanically regulated, transforming growth factor-beta 1-induced myofibroblast differentiation of aortic valve interstitial cells","volume":"31","author":"Chen","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1105","doi-asserted-by":"crossref","first-page":"6593","DOI":"10.1016\/j.biomaterials.2009.08.031","article-title":"Characterization of valvular interstitial cell function in three dimensional matrix metalloproteinase degradable PEG hydrogels","volume":"30","author":"Benton","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.10.009_bb1110","first-page":"56","article-title":"Characterization of structural and signaling molecules by human valve interstitial cells and comparison to human mesenchymal stem cells","volume":"16","author":"Latif","year":"2007","journal-title":"J. Heart Valve Dis."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1115","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1021\/bm100211k","article-title":"Effect of heparin oligomer chain length on the activation of valvular interstitial cells","volume":"11","author":"Pedron","year":"2010","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2014.10.009_bb1120","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1525-1594.2009.00824.x","article-title":"Aging adversely impacts biological properties of human bone marrow-derived mesenchymal stem cells: implications for tissue engineering heart valve construction","volume":"34","author":"Xin","year":"2010","journal-title":"Artif. Organs"},{"key":"10.1016\/j.jconrel.2014.10.009_bb1125","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1039\/B914460A","article-title":"Microfabricated arrays for high-throughput screening of cellular response to cyclic substrate deformation","volume":"10","author":"Moraes","year":"2010","journal-title":"Lab Chip"},{"key":"10.1016\/j.jconrel.2014.10.009_bb1130","doi-asserted-by":"crossref","first-page":"19943","DOI":"10.1073\/pnas.1106954108","article-title":"Cyclic strain induces dual-mode endothelial-mesenchymal transformation of the cardiac valve","volume":"108","author":"Balachandran","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1135","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1525-1594.2009.00742.x","article-title":"Fabrication of a novel hybrid heart valve leaflet for tissue engineering: an in vitro study","volume":"33","author":"Hong","year":"2009","journal-title":"Artif. Organs"},{"key":"10.1016\/j.jconrel.2014.10.009_bb1140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054622","article-title":"The effect of heparin-VEGF multilayer on the biocompatibility of decellularized aortic valve with platelet and endothelial progenitor cells","volume":"8","author":"Ye","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jconrel.2014.10.009_bb1145","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1089\/ten.tea.2008.0545","article-title":"Photocrosslinking of gelatin macromers to synthesize porous hydrogels that promote valvular interstitial cell function","volume":"15","author":"Benton","year":"2009","journal-title":"Tissue Eng. A"},{"key":"10.1016\/j.jconrel.2014.10.009_bb1150","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.biomaterials.2009.10.019","article-title":"The role of organ level conditioning on the promotion of engineered heart valve tissue development in-vitro using mesenchymal stem cells","volume":"31","author":"Ramaswamy","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.10.009_bb1155","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.2174\/138161210791920513","article-title":"Current formulations and techniques of drug\/gene delivery for targeted therapy and tissue engineering","volume":"16","author":"Wang","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1160","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S1525-0016(16)38625-7","article-title":"Targeted therapy of metastatic melanoma using neural stem cell-based drug delivery","volume":"17","author":"Gutova","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1165","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.addr.2007.03.017","article-title":"Matrices and scaffolds for DNA delivery in tissue engineering","volume":"59","author":"De Laporte","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1170","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.copbio.2005.10.009","article-title":"Nanotechnology for drug and gene therapy: the importance of understanding molecular mechanisms of delivery","volume":"16","author":"Labhasetwar","year":"2005","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1175","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1021\/bp060348j","article-title":"Nanoparticle-mediated drug delivery and gene therapy","volume":"23","author":"Jin","year":"2007","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1180","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.gt.3302129","article-title":"Localized gene delivery using antibody tethered adenovirus from polyurethane heart valve cusps and intra-aortic implants","volume":"11","author":"Stachelek","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1185","first-page":"682","article-title":"Animal study of intravascular gene therapy based on polyurethane implantable devices","volume":"28","author":"Song","year":"2006","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"10.1016\/j.jconrel.2014.10.009_bb1190","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/jbm.a.34055","article-title":"Advanced polymeric matrix for valvular complications","volume":"100A","author":"Acharya","year":"2012","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2014.10.009_bb1195","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-2005-922362","article-title":"Polymer based DNA matrices for heart valve tissue engineering","volume":"53","author":"Ma","year":"2005","journal-title":"Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1200","first-page":"148","article-title":"Thrombogenicity of central vein catheters\u2014comparison of 2 polyurethane catheters","volume":"20","author":"Schwarzmann","year":"1993","journal-title":"Infusionsther. Transfusionsmed."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1205","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1016\/S0142-9612(02)00224-7","article-title":"Activated polyurethane modified with latent thiol groups","volume":"23","author":"Alferiev","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2014.10.009_bb1210","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.athoracsur.2005.07.061","article-title":"Cholesterol-modified polyurethane valve cusps demonstrate blood outgrowth endothelial cell adhesion post-seeding in vitro and in vivo","volume":"81","author":"Stachelek","year":"2006","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1215","doi-asserted-by":"crossref","first-page":"727-+","DOI":"10.1016\/S1052-5149(25)00749-X","article-title":"Minimally invasive procedures\u2014advances in image-guided delivery of drug and cell therapies into the central nervous system","volume":"11","author":"Broaddus","year":"2001","journal-title":"Neuroimaging Clin. N. Am."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1220","doi-asserted-by":"crossref","first-page":"I378","DOI":"10.1161\/CIRCULATIONAHA.105.001016","article-title":"Development of a new method for endovascular aortic repair\u2014combination therapy of cell transplantation and stent grafts with a drug delivery system","volume":"114","author":"Kajimoto","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2014.10.009_bb1225","doi-asserted-by":"crossref","first-page":"38571","DOI":"10.1074\/jbc.M206689200","article-title":"Functional linkage between the endoplasmic reticulum protein Hsp47 and procollagen expression in human vascular smooth muscle cells","volume":"277","author":"Rocnik","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1230","series-title":"FMBE Proceedings","article-title":"Tissue engineering of heart valve leaflet by self-assembly of tissue spheroids biofabricated from human fat tissue derived stem cells","author":"Mironov","year":"2010"},{"key":"10.1016\/j.jconrel.2014.10.009_bb1235","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1161\/01.CIR.101.20.2345","article-title":"Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase","volume":"101","author":"Lee","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2014.10.009_bb1240","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/jcb.24031","article-title":"Oxidative-mechanical stress signals stem cell niche mediated Lrp5 osteogenesis in eNOS(\u2212\/\u2212) null mice","volume":"113","author":"Rajamannan","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1245","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bbrc.2014.03.131","article-title":"Stem cells with FGF4-bFGF fused gene enhances the expression of bFGF and improves myocardial repair in rats","volume":"447","author":"Chen","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1250","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.bbrc.2009.01.019","article-title":"Transplantation of adipose-derived stem cells overexpressing hHGF into cardiac tissue","volume":"379","author":"Zhu","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1255","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/cvr\/cvr053","article-title":"VEGF\/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart","volume":"91","author":"Tang","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1260","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jacc.2005.05.079","article-title":"Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector","volume":"46","author":"Tang","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1265","article-title":"Studies on Tissue Engineering Heart Valve Construction with Human Endothelial Progenitor Cells Transfected by Ad.FnCBD64","author":"GuangJie","year":"2006"},{"key":"10.1016\/j.jconrel.2014.10.009_bb1270","first-page":"1622","article-title":"Application of transforming growth factor-beta(1) on construction of tissue engineering heart valves: experimental in vitro","volume":"87","author":"Dong","year":"2007","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.jconrel.2014.10.009_bb1275","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.addr.2006.03.002","article-title":"Cardiovascular gene delivery: The good road is awaiting","volume":"58","author":"Brewster","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1280","series-title":"IFMBE Proceedings","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1007\/978-3-642-14515-5_303","article-title":"VEGF-Transfected Human Endothelial Cell Coating on Stents Promotes Re-endothelization and Inhibits In-stent Restenosis","author":"Wang","year":"2010"},{"key":"10.1016\/j.jconrel.2014.10.009_bb1285","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jvs.2010.08.020","article-title":"The impact of vascular endothelial growth factor-transfected human endothelial cells on endothelialization and restenosis of stainless steel stents","volume":"53","author":"Tang","year":"2011","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.jconrel.2014.10.009_bb1290","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejpb.2013.03.022","article-title":"Adipose-derived stem cells combined with neuregulin-1 delivery systems for heart tissue engineering","volume":"85","author":"Diaz-Herraez","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914006841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365914006841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T10:28:12Z","timestamp":1746440892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365914006841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":258,"alternative-id":["S0168365914006841"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.10.009","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug delivery in aortic valve tissue engineering","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2014.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}